Since aberrant STAT3 activation is widely implicated in epithelial tumorigenesis, including cutaneous SCC, and its constitutive phosphorylation upregulates pro-survival and pro-proliferative genes, these changes are mechanistically consistent with delayed tumor development [60]. The gene discussed is STAT3; the disease is neoplasm.